title: Removal from liver transplantation list of a hepatitis C virus-HIV co-infected patient after successful treatment with sofosbuvir and daclatasvir.
abstract: We present a human immunodeficiency virus-infected patient with severe decompensated hepatitis C virus-related cirrhosis awaiting liver transplantation (LT) who received a 24-week course of interferon/ribavirin-free antiviral treatment with sofosbuvir and daclatasvir on a compassionate basis. Rapid viral suppression was associated with progressive improvement of his liver function tests. The patient achieved a sustained virological response and concomitant clinical improvement, which prompted removal from the LT list 12 weeks after the end of treatment.
authors.affiliation: Liver Unit, Internal Medicine Department, Hospital Universitari Vall Hebron, Barcelona, Univeristat Autònoma de Barcelona, Barcelona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Llaneras
authors.affiliation: Liver Unit, Internal Medicine Department, Hospital Universitari Vall Hebron, Barcelona, Univeristat Autònoma de Barcelona, Barcelona, Spain.|Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
authors.forename: L
authors.initials: L
authors.lastname: Castells
authors.affiliation: Liver Unit, Internal Medicine Department, Hospital Universitari Vall Hebron, Barcelona, Univeristat Autònoma de Barcelona, Barcelona, Spain.
authors.forename: B
authors.initials: B
authors.lastname: Santos
authors.affiliation: Infectious Disease Unit, Internal Medicine Department, Hospital Universitari Vall Hebron, Barcelona, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Crespo
authors.affiliation: HIV Unit, Internal Medicine Department, Hospital Universitari Arnau de Vilanova de Lleida, Universitat de Lleida, Lleida, Spain.
authors.forename: T
authors.initials: T
authors.lastname: Puig
authors.affiliation: Liver Unit, Internal Medicine Department, Hospital Universitari Vall Hebron, Barcelona, Univeristat Autònoma de Barcelona, Barcelona, Spain.|Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
authors.forename: J I
authors.initials: JI
authors.lastname: Esteban
authors.affiliation: Liver Unit, Internal Medicine Department, Hospital Universitari Vall Hebron, Barcelona, Univeristat Autònoma de Barcelona, Barcelona, Spain.|Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
authors.forename: R
authors.initials: R
authors.lastname: Esteban
keywords: daclatasvir; hepatitis C virus; human immunodeficiency virus; sofosbuvir; transplant